financetom
Business
financetom
/
Business
/
Clariant completes $810 mln acquisition of Lucas Meyer Cosmetics
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Clariant completes $810 mln acquisition of Lucas Meyer Cosmetics
Apr 2, 2024 9:55 PM

April 3 (Reuters) - Clariant completed the $810

million acquisition of Canada's ingredients and cosmetics maker

Lucas Meyer Cosmetics from International Flavors & Fragrances ( IFF )

, the Swiss specialty chemicals firm said on Wednesday.

($1 = 0.9079 Swiss francs)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kazakhstan's daily oil output at record high amid Chevron-led expansion
Kazakhstan's daily oil output at record high amid Chevron-led expansion
Jan 27, 2025
MOSCOW (Reuters) - Oil production in Kazakhstan reached a daily record high of 278,499 metric tons on Sunday just after it embarked on an expansion of its largest oilfield, Chevron ( CVX )-led Tengiz, according to official data. Kazakhstan - which relies on Tengiz and two other major fields, Karachaganak and Kashagan, for most of its production - is subject...
AT&T Q4 Adjusted Earnings Flat, Revenue Rises; 2025 Outlook Issued -- Shares Up Pre-Bell
AT&T Q4 Adjusted Earnings Flat, Revenue Rises; 2025 Outlook Issued -- Shares Up Pre-Bell
Jan 27, 2025
06:42 AM EST, 01/27/2025 (MT Newswires) -- AT&T ( T ) reported Q4 adjusted earnings Monday of $0.54 per share, same as a year earlier. Analysts polled by FactSet expected $0.50. Total operating revenue for the quarter ended Dec. 31 was $32.30 billion, compared with $32.02 billion a year earlier. Analysts surveyed by FactSet expected $32.02 billion. The company said...
Maze Therapeutics targets up to $728 mln valuation in US IPO
Maze Therapeutics targets up to $728 mln valuation in US IPO
Jan 27, 2025
Jan 27 (Reuters) - Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial public offering in the United States. The South San Francisco, California-based company is seeking up to $132.6 million by offering 7.8 million shares priced between $15 and $17 each. The IPO could be one of...
Brazil's JBS buys stake in Mantiqueira to enter egg sector
Brazil's JBS buys stake in Mantiqueira to enter egg sector
Jan 27, 2025
SAO PAULO, Jan 27 (Reuters) - Brazilian meatpacker JBS said on Monday it has agreed to buy a stake in Mantiqueira Alimentos, marking the food giant's entry into the egg sector in a deal that valued Mantiqueira at 1.9 billion reais ($321 million). JBS said in a securities filing it had agreed to purchase shares representing 48.5% of the total...
Copyright 2023-2026 - www.financetom.com All Rights Reserved